Latest period
$43.37B
YoY change
+26.3%
5Y CAGR
+20.7%
Peak year (2025)
$42.50B
Latest annual
$42.50B
Total Debt history chart for Eli Lilly (LLY) from 1985 to 2025
Latest: $42.50B
Total Debt growth chart for Eli Lilly (LLY) from 1985 to 2025
Latest: +26.3%
Total Debt history table for Eli Lilly (LLY) from 1985 to 2025
| 2025 | $42.50B | +26.3% | +$8.86B | ||
| 2024 | $33.64B | +33.4% | +$8.42B | ||
| 2023 | $25.23B | +55.3% | +$8.99B | ||
| 2022 | $16.24B | -3.8% | −$646.10M | ||
| 2021 | $16.88B | +1.7% | +$289.40M | ||
| 2020 | $16.60B | +5.0% | +$791.40M | ||
| 2019 | $15.80B | +53.5% | +$5.51B | ||
| 2018 | $10.30B | -24.5% | −$3.35B | ||
| 2017 | $13.65B | +32.4% | +$3.34B | ||
| 2016 | $10.31B | +29.2% | +$2.33B | ||
| 2015 | $7.98B | -1.0% | −$77.90M | ||
| 2014 | $8.06B | +54.5% | +$2.84B | ||
| 2013 | $5.21B | -5.8% | −$318.40M | ||
| 2012 | $5.53B | -20.8% | −$1.46B | ||
| 2011 | $6.99B | +0.9% | +$60.50M | ||
| 2010 | $6.93B | +4.0% | +$264.40M | ||
| 2009 | $6.66B | -36.3% | −$3.80B | ||
| 2008 | $10.46B | +108.9% | +$5.45B | ||
| 2007 | $5.01B | +34.8% | +$1.29B | ||
| 2006 | $3.71B | -42.8% | −$2.78B | ||
| 2005 | $6.50B | -0.2% | −$14.30M | ||
| 2004 | $6.51B | +33.3% | +$1.63B | ||
| 2003 | $4.88B | -0.4% | −$19.30M | ||
| 2002 | $4.90B | +43.4% | +$1.49B | ||
| 2001 | $3.42B | +21.3% | +$600.40M | ||
| 2000 | $2.82B | -7.7% | −$235.40M | ||
| 1999 | $3.05B | +29.0% | +$686.50M | ||
| 1998 | $2.37B | -7.3% | −$186.80M | ||
| 1997 | $2.55B | -31.5% | −$1.18B | ||
| 1996 | $3.73B | -17.2% | −$772.30M | ||
| 1995 | $4.50B | -7.2% | −$348.50M | ||
| 1994 | $4.85B | +256.6% | +$3.49B | ||
| 1993 | $1.36B | +15.9% | +$186.50M | ||
| 1992 | $1.17B | +8.1% | +$87.80M | ||
| 1991 | $1.09B | -28.4% | −$430.80M | ||
| 1990 | $1.52B | +275.8% | +$1.11B | ||
| 1989 | $403.50M | -21.6% | −$111.20M | ||
| 1988 | $514.70M | -14.8% | −$89.20M | ||
| 1987 | $603.90M | -3.6% | −$22.30M | ||
| 1986 | $626.20M | +162.4% | +$387.60M | ||
| 1985 | $238.60M | — | — |
- 2025$42.50B+26.3%
- 2024$33.64B+33.4%
- 2023$25.23B+55.3%
- 2022$16.24B-3.8%
- 2021$16.88B+1.7%
- 2020$16.60B+5.0%
- 2019$15.80B+53.5%
- 2018$10.30B-24.5%
- 2017$13.65B+32.4%
- 2016$10.31B+29.2%
- 2015$7.98B-1.0%
- 2014$8.06B+54.5%
- 2013$5.21B-5.8%
- 2012$5.53B-20.8%
- 2011$6.99B+0.9%
- 2010$6.93B+4.0%
- 2009$6.66B-36.3%
- 2008$10.46B+108.9%
- 2007$5.01B+34.8%
- 2006$3.71B-42.8%
- 2005$6.50B-0.2%
- 2004$6.51B+33.3%
- 2003$4.88B-0.4%
- 2002$4.90B+43.4%
- 2001$3.42B+21.3%
- 2000$2.82B-7.7%
- 1999$3.05B+29.0%
- 1998$2.37B-7.3%
- 1997$2.55B-31.5%
- 1996$3.73B-17.2%
- 1995$4.50B-7.2%
- 1994$4.85B+256.6%
- 1993$1.36B+15.9%
- 1992$1.17B+8.1%
- 1991$1.09B-28.4%
- 1990$1.52B+275.8%
- 1989$403.50M-21.6%
- 1988$514.70M-14.8%
- 1987$603.90M-3.6%
- 1986$626.20M+162.4%
- 1985$238.60M—
Total Debt values are taken from Eli Lilly's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Debt at Eli Lilly (LLY)
According to Eli Lilly's latest reported financial statements, the company's latest reported total debt is $43.37B. Total debt is the sum of short-term and long-term interest-bearing borrowings on the balance sheet (notes, bonds, term loans, lease liabilities). Useful for leverage and refinancing risk — compare with cash on hand for net leverage, and total liabilities for the broader obligations picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2025's annual total debt for Eli Lilly (LLY) came in at $42.50B – grew 26.3% year-over-year.
Across 2020–2025 (5 years), Eli Lilly total debt produced a CAGR of +20.7% – with mixed annual results across the window.
2025 marks the peak total debt at $42.50B, with the historical low of $238.60M recorded in 1985.
Eli Lilly Total Debt by Year
Eli Lilly Total Debt 2025: $42.50B
2025's total debt for Eli Lilly came in at $42.50B, grew 26.3% from 2024. This figure represents the highest annual value in the available history.
Eli Lilly Total Debt 2024: $33.64B
Eli Lilly posted total debt of $33.64B in 2024, surged 33.4% from 2023.
Eli Lilly Total Debt 2023: $25.23B
In 2023, Eli Lilly reported total debt of $25.23B, surged 55.3% from 2022.
Eli Lilly Total Debt 2022: $16.24B
Eli Lilly total debt in 2022 was $16.24B, edged down 3.8% below 2021.
Eli Lilly Total Debt 2021: $16.88B
Eli Lilly total debt in 2021 was $16.88B.
See more financial history for Eli Lilly (LLY).
Sector peers by Total Debt
Healthcare peers of Eli Lilly (LLY), ranked by their latest total debt
| $78.39B | |
| $69.07B | |
| $54.60B | |
| $50.53B | |
| $47.93B | |
| $40.85B | |
| $29.70B | |
| $20.59B |
- $78.39B
- $69.07B
- $54.60B
- $50.53B
- $47.93B
- $29.70B
- $20.59B
Frequently asked questions
Eli Lilly (LLY) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation